Results 201 to 210 of about 53,318 (258)

Hemorrhagic Complications in Patients with Atrial Fibrillation Treated with Novel Oral Anticoagulants: Results from the CRAFT Study. [PDF]

J Clin Med
Styczkiewicz M, Wawrzeńczyk M, Sukiennik A, Krzowski B, Maciejewski C, Lodziński P, Kraj L, Opolski G, Grabowski M, Balsam P, Peller M.   +10 more
europepmc   +1 more source

Cardioprotective Effects of Rivaroxaban on Cardiac Remodeling After Experimental Myocardial Infarction in Mice

, 2020
Nobuhiro Nakanishi, Koichi Kaikita, Masanobu Ishii, Yu Oimatsu, Tatsuro Mitsuse, Miwa Ito, Kenshi Yamanaga, Koichiro Fujisue, Hisanori Kanazawa, Daisuke Sueta, Seiji Takashio, Yuichiro Arima, Satoshi Araki, Taishi Nakamura, Kenji Sakamoto, Satoru Suzuki, Eiichiro Yamamoto, Hirofumi Soejima, Kenichi Tsujita   +18 more
openalex   +2 more sources

Anticoagulation to prevent ischemic stroke and neurocognitive impairment in atrial fibrillation: the BRAIN-AF randomized clinical trial. [PDF]

Nat Med
Rivard L, Khairy P, Talajic M, Tardif JC, Healey JS, Black SE, Andrade JG, Field TS, Nault I, Bherer L, Massoud F, Nattel S, Lanthier S, Racine N, Roux JF, Greiss I, Macle L, Guerra PG, Tadros R, Mayrand H, Gosselin G, Conen D, Bocti C, Chayer C, Deschaintre Y, Sandhu RK, Manlucu J, Khaykin Y, Verma A, Mondésert B, Dyrda K, Cadrin-Tourigny J, Thibault B, Raymond-Paquin A, Aguilar M, Brouillette J, Roussin A, Robillard A, Tremblay-Gravel M, David LP, Cossette M, Parkash R, Guertin MC, Roy D, BRAIN-AF investigators, Pandey AS, Pichette F, Barrero M, Kus T, Lemieux A, Gaudreault V, Marzban P, Wong J, Sit PL, Laflamme D, Fowlis R, Quadros K, Kapoor A, Jolly US, Wilton S, Azzari FA, Dorian P, Deslongchamps F, Pesant Y, Vizel S, Maung T, Heffernan M, Nery P, Curnew G, Bourgeois S, Essebag V, Kouz S, Cormier L, Vyselaar J, Chehayeb R, Khoo C, Gupta A, Bessoudo R, Bhargava R, Sandrin F, Schram G, St-Maurice F, Tsui W, Liang W.   +83 more
europepmc   +1 more source

Direct oral anticoagulant rivaroxaban for secondary prevention of catheter-related thrombosis in children with intestinal failure: real-life data. [PDF]

Res Pract Thromb Haemost
Hilberath J, Ballauff A, Rückel A, Sieverding L, Vermeulen D, Eberl W, Hartleif S, Lieber J, Michel J, Sturm E, Nordmeyer J, Icheva V.   +11 more
europepmc   +1 more source

Economic Evaluation of Direct Oral Anticoagulants Versus Low-Molecular Weight Heparin for Cancer-Associated Thrombosis in a Thai University-Affiliated Hospital. [PDF]

J Clin Med
Chaiwattanakowit T, Pinitpracharome N, Dilokthornsakul W, Akrawikrai T, Dilokthornsakul P.   +4 more
europepmc   +1 more source

Trends and Hot Spots in Research Related to Rivaroxaban: Bibliometric Analysis. [PDF]

Clin Pract
Pawlak K, Kruszyna Ł, Wesołowska A, Karaźniewicz-Łada M.   +3 more
europepmc   +1 more source

Application Value and Safety Analysis of Warfarin, Rivaroxaban, and Dabigatran Ester in Elderly Patients With Atrial Fibrillation [PDF]

Cheng Chen, Qing Tian, Chong Cheng, Xixin Ji, Mengyun Feng, Huiqun Tan, Qian Zhou   +6 more
openalex   +1 more source

Predictors of Direct Oral Anticoagulant Use in Northern Italy: A Population-Based Study. [PDF]

Pharmacoepidemiol Drug Saf
Ojeda-Fernández L, Agostini G, Zanovello A, Prada P, Fortino I, Augurio C, Baviera M.   +6 more
europepmc   +1 more source

Impact of NSAID Use on Bleeding Rates for Patients Taking Rivaroxaban or Apixaban. [PDF]

Rebecca Worsham, R. Darren Wood, Alan Radford   +2 more
openalex   +1 more source

Assess the reporting quality of randomized controlled clinical trials exploring the efficacy and safety of new anticoagulants versus warfarin in patients with atrial fibrillation based on CONCORT statement [PDF]

, 2016
Μαντζουράτου, Πολυξένη Δ.
core   +1 more source